CORRESP Filing
Propanc Biopharma, Inc.
Date: Feb. 12, 2026 · CIK: 0001517681 · Accession: 0001493152-26-006497
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293147
Letter
Re: Propanc Biopharma, Inc.
United States Securities and Exchange Commission
Division of Corporation Finance
Attn: Jimmy McNamara
100 F Street, N.E.
Washington, DC 20549
Registration Statement on Form S-1
Filed February 2, 2026
File No. 333-293147
REQUEST FOR WITHDRAWAL OF ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Reference is made to our letter, dated February 10, 2026 in which we requested acceleration of the effective date of the above referenced Registration Statement to February 12, 2026 at 9:30 a.m. Eastern Standard Time. We are no longer requesting that such Registration Statement be declared effective at such time, and we hereby formally, and with immediate effect, withdraw our request for acceleration of the effective date.
Very
truly yours,
Propanc
Biopharma, Inc.
Show Raw Text
CORRESP 1 filename1.htm United States Securities and Exchange Commission Division of Corporation Finance Attn: Jimmy McNamara 100 F Street, N.E. Washington, DC 20549 Re: Propanc Biopharma, Inc. Registration Statement on Form S-1 Filed February 2, 2026 File No. 333-293147 REQUEST FOR WITHDRAWAL OF ACCELERATION OF EFFECTIVENESS Ladies and Gentlemen: Reference is made to our letter, dated February 10, 2026 in which we requested acceleration of the effective date of the above referenced Registration Statement to February 12, 2026 at 9:30 a.m. Eastern Standard Time. We are no longer requesting that such Registration Statement be declared effective at such time, and we hereby formally, and with immediate effect, withdraw our request for acceleration of the effective date. Very truly yours, Propanc Biopharma, Inc. By: /s/ James Nathanielsz Name: James Nathanielsz Title: Chief Operating Officer